sivelestat has been researched along with Brain Edema in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, S; Ikegame, Y; Iwama, T; Nakashima, S; Yamashita, K; Yoshimura, S | 1 |
| Ikeda, Y; Kamanaka, Y; Kondo, K; Shimakura, A; Suzuki, Y; Umemura, K | 1 |
2 other study(ies) available for sivelestat and Brain Edema
| Article | Year |
|---|---|
Neutrophil elastase inhibitor prevents ischemic brain damage via reduction of vasogenic edema.
Topics: Acute Disease; Angiopoietin-1; Animals; Blood-Brain Barrier; Brain Edema; Capillary Permeability; Cells, Cultured; Glycine; Humans; Hypoxia-Ischemia, Brain; Leukocyte Elastase; Male; Mice; Mice, Inbred C57BL; Microvessels; Proteinase Inhibitory Proteins, Secretory; Sulfonamides | 2010 |
Neutrophil elastase inhibition reduces cerebral ischemic damage in the middle cerebral artery occlusion.
Topics: Animals; Antilymphocyte Serum; Brain Edema; Brain Ischemia; Cell Count; Cerebral Cortex; Corpus Striatum; Dose-Response Relationship, Drug; Glycine; Infarction, Middle Cerebral Artery; Infusions, Intravenous; Leukocyte Elastase; Male; Neutrophils; Rats; Rats, Wistar; Rose Bengal; Serine Proteinase Inhibitors; Sulfonamides | 2000 |